Persistent URL of this record https://hdl.handle.net/1887/3750461
Documents
-
- Download
- PIIS0923753422047858
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- •This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing non-oncogene-addicted mNSCLC.
- •ESMO-MCBS scores are given to describe the levels of evidence for treatment choices.
- •ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.
- •Recommendations are based on available scientific data and the authors’ collective expert opinion.
- •In clinical practice, all recommendations provided need to be discussed with patients in a shared decision-making approach.
- All authors
- Hendriks, L.E.; Kerr, K.M.; Menis, J.; Mok, T.S.; Nestle, U.; Passaro, A.; Planchard, D.; Peters, S.; Smit, E.F.; Solomon, B.J.; Veronesi, G.; Reck, M.; SMO Guidelines Comm
- Date
- 2023-04-14
- Journal
- Annals of Oncology
- Volume
- 34
- Issue
- 4
- Pages
- 358 - 376
- Link
- https://www.annalsofoncology.org/article/S0923-7534(22)04785-8/fulltext